This trial will help researchers learn more about how the commonly prescribed painkiller oxycodone affects children by studying its metabolic activity and performing genetic testing.
1 Primary · 0 Secondary · Reporting Duration: The 10 samples will be drawn at the following time points: 8 blood samples will be taken at 30 minutes, 1, 1.5, 2, 3, 4, 5, and 6 hours post-dose in every patient along other 2 samples at approximately either 8 and 12 or 10 and 24 hours post-dose.
Experimental Treatment
68 Total Participants · 1 Treatment Group
Primary Treatment: oral oxycodone · No Placebo Group · Phase 4
Age < 18 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: